IXC 2.86% 7.2¢ invex therapeutics ltd

Ann: Invex Granted European Orphan Drug Designation for TBI, page-41

  1. 1,519 Posts.
    lightbulb Created with Sketch. 506
    So is this similar to the FDA version of ODD? The benefits only apply if the first marketing approval is for that indication.

    If so, this ODD won't be worth anything to us unless we fail on the IIH indication, given that is far more advanced.

    So a backup ODD if you will.
    Last edited by reon1: 24/06/23
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $1.701K 23.62K

Buyers (Bids)

No. Vol. Price($)
2 76375 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.